159 related articles for article (PubMed ID: 12369230)
1. The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants.
Mrus JM; Yi MS; Eckman MH; Tsevat J
Med Decis Making; 2002; 22(5 Suppl):S38-44. PubMed ID: 12369230
[TBL] [Abstract][Full Text] [Related]
2. Rational testing of the HIV-exposed infant.
Benjamin DK; Miller WC; Fiscus SA; Benjamin DK; Morse M; Valentine M; McKinney RE
Pediatrics; 2001 Jul; 108(1):E3. PubMed ID: 11433082
[TBL] [Abstract][Full Text] [Related]
3. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
4. Projected cost-effectiveness of statewide universal newborn hearing screening.
Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
6. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
8. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States.
Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):403-16. PubMed ID: 11141240
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings.
Menzies NA; Homsy J; Chang Pitter JY; Pitter C; Mermin J; Downing R; Finkbeiner T; Obonyo J; Kekitiinwa A; Tappero J; Blandford JM
Pediatr Infect Dis J; 2009 Sep; 28(9):819-25. PubMed ID: 20050391
[TBL] [Abstract][Full Text] [Related]
10. False-positive HIV DNA PCR testing of infants: implications in a changing epidemic.
Feucht UD; Forsyth B; Kruger M
S Afr Med J; 2012 Feb; 102(3 Pt 1):149-52. PubMed ID: 22380909
[TBL] [Abstract][Full Text] [Related]
11. Reducing the cost of HIV antibody testing.
Tamashiro H; Maskill W; Emmanuel J; Fauquex A; Sato P; Heymann D
Lancet; 1993 Jul; 342(8863):87-90. PubMed ID: 8100916
[TBL] [Abstract][Full Text] [Related]
12. Vertical transmission of HIV in New York State: a basis for statewide testing of newborns.
Charbonneau TT; Wade NA; Weiner L; Omene J; Frenkel L; Wethers JA; Arpadi S; Bamji M; Frey HM; Gupta A; Conroy JM
AIDS Patient Care STDS; 1997 Aug; 11(4):227-36. PubMed ID: 11361837
[TBL] [Abstract][Full Text] [Related]
13. Vertical transmission of human immunodeficiency virus from seronegative or indeterminate mothers.
Johnson JP; Vink PE; Hines SE; Robinson B; Davis JC; Nair P
Am J Dis Child; 1991 Nov; 145(11):1239-41. PubMed ID: 1951213
[TBL] [Abstract][Full Text] [Related]
14. Birth Testing for Infant HIV Diagnosis in Eswatini: Implementation Experience and Uptake Among Women Living With HIV in Manzini Region.
Teasdale CA; Tsiouris F; Mafukidze A; Shongwe S; Choy M; Nhlengetfwa H; Simelane S; Mthethwa S; Ao T; Ryan C; Dale H; Rivadeneira E; Abrams EJ
Pediatr Infect Dis J; 2020 Sep; 39(9):e235-e241. PubMed ID: 32453193
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
[TBL] [Abstract][Full Text] [Related]
16. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.
Haberland CA; Benitz WE; Sanders GD; Pietzsch JB; Yamada S; Nguyen L; Garber AM
Pediatrics; 2002 Sep; 110(3):471-80. PubMed ID: 12205247
[TBL] [Abstract][Full Text] [Related]
17. An Early Infant HIV Risk Score for Targeted HIV Testing at Birth.
Du Plessis NM; Muller CJB; Avenant T; Pepper MS; Goga AE
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31101703
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification.
Nelson RP; Price LJ; Halsey AB; Graven SN; Resnick L; Day NK; Lockey RF; Good RA
Arch Pediatr Adolesc Med; 1996 Jan; 150(1):40-5. PubMed ID: 8542005
[TBL] [Abstract][Full Text] [Related]
19. Whose blood is safer? The effect of the stage of the epidemic on screening for HIV.
Litvak E; Siegel JE; Pauker SG; Lallemant M; Fineberg HV; Weinstein MC
Med Decis Making; 1997; 17(4):455-63. PubMed ID: 9343804
[TBL] [Abstract][Full Text] [Related]
20. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
